Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT).
Ubink I, Bloemendal HJ, Elias SG, Brink MA, Schwartz MP, Holierhoek YCW, Verheijen PM, Boerman AW, Mathijssen RHJ, de Leng WWJ, de Weger RA, van Grevenstein WMU, Koopman M, Lolkema MP, Kranenburg O, Borel Rinkes IHM.
Ubink I, et al. Among authors: borel rinkes ihm.
BMC Cancer. 2017 Apr 19;17(1):282. doi: 10.1186/s12885-017-3264-y.
BMC Cancer. 2017.
PMID: 28424071
Free PMC article.